109 related articles for article (PubMed ID: 24448129)
1. Long-term prognosis of pemphigus in central Kerala, India: a retrospective cohort study.
Ajithkumar K
Indian J Dermatol Venereol Leprol; 2014; 80(1):64-5. PubMed ID: 24448129
[No Abstract] [Full Text] [Related]
2. Curative treatment for pemphigus.
Pasricha JS; Khaitan BK
Arch Dermatol; 1996 Dec; 132(12):1518-9. PubMed ID: 8961890
[No Abstract] [Full Text] [Related]
3. Dexamethasone-cyclophosphamide pulse therapy in pemphigus: a review of 72 cases.
Zivanovic D; Medenica L; Tanasilovic S; Vesic S; Skiljevic D; Tomovic M; Nikolic MM
Am J Clin Dermatol; 2010; 11(2):123-9. PubMed ID: 20141233
[TBL] [Abstract][Full Text] [Related]
4. Pemphigus herpetiformis with an autoimmune response to recombinant desmoglein 1.
Seitz CS; Staegemeir E; Amagai M; Rose C; Bröcker EB; Zillikens D
Br J Dermatol; 1999 Aug; 141(2):354-5. PubMed ID: 10469475
[No Abstract] [Full Text] [Related]
5. [Localized pemphigus].
Kharfi M; Fazaa B; Benmously R; Bouden S; Elloumi L; Kamoun MR
Ann Dermatol Venereol; 2003; 130(6-7):645-7. PubMed ID: 13679705
[No Abstract] [Full Text] [Related]
6. Dexamethasone-cyclophosphamide pulse therapy for autoimmune-vesiculobullous disorders at Victoria hospital, Bangalore.
Sacchidanand S; Hiremath NC; Natraj HV; Revathi TN; Rani S; Pradeep G; Tenneti V
Dermatol Online J; 2003 Dec; 9(5):2. PubMed ID: 14996375
[TBL] [Abstract][Full Text] [Related]
7. Pulsed intravenous cyclophosphamide and methylprednisolone therapy in refractory pemphigus.
Saha M; Powell AM; Bhogal B; Black MM; Groves RW
Br J Dermatol; 2010 Apr; 162(4):790-7. PubMed ID: 19922532
[TBL] [Abstract][Full Text] [Related]
8. Prolonged remission of pemphigus induced by dexamethasone-cyclophosphamide pulse therapy.
Gupta R
Indian J Dermatol Venereol Leprol; 2007; 73(2):121-2. PubMed ID: 17456923
[No Abstract] [Full Text] [Related]
9. Treatment of severe pemphigus vulgaris of the scalp with adjuvant rituximab and immunoadsorption.
Kamphausen I; Schulze F; Schmidt E; Zillikens D; Kunz M
Eur J Dermatol; 2012; 22(6):786-7. PubMed ID: 23114083
[No Abstract] [Full Text] [Related]
10. Factors affecting the duration of phase I of dexamethasone - cyclophosphamide pulse therapy.
Nayak CS; Ray S; Thombre A; Jain M
Indian J Dermatol Venereol Leprol; 2014; 80(4):296-9. PubMed ID: 25035352
[TBL] [Abstract][Full Text] [Related]
11. Twelve-year clinico-therapeutic experience in pemphigus: a retrospective study of 54 cases.
Mahajan VK; Sharma NL; Sharma RC; Garg G
Int J Dermatol; 2005 Oct; 44(10):821-7. PubMed ID: 16207182
[TBL] [Abstract][Full Text] [Related]
12. Curative effect of dexamethasone-cyclophosphamide pulse therapy for the treatment of pemphigus vulgaris.
Pasricha JS; Das SS
Int J Dermatol; 1992 Dec; 31(12):875-7. PubMed ID: 1478770
[TBL] [Abstract][Full Text] [Related]
13. Pemphigus vulgaris treated with adalimumab: case study.
Vojáčková N; Fialová J; Vaňousová D; Hercogová J
Dermatol Ther; 2012; 25(1):95-7. PubMed ID: 22591504
[TBL] [Abstract][Full Text] [Related]
14. A review of pulse therapy in 74 patients with pemphigus.
Roga G; Augustine M
Indian J Dermatol Venereol Leprol; 2018; 84(3):331-333. PubMed ID: 29600798
[No Abstract] [Full Text] [Related]
15. Treatment of pemphigus: a local experience.
Akhtar SJ; Hasan MU
J Pak Med Assoc; 1998 Oct; 48(10):300-4. PubMed ID: 10087750
[TBL] [Abstract][Full Text] [Related]
16. Etiology of pyrexia in pemphigus patients: a dermatologist's enigma.
Qadim HH; Hasani A; Zinus BM; Orang NJ; Hasani A
Indian J Dermatol Venereol Leprol; 2012; 78(6):774. PubMed ID: 23075657
[No Abstract] [Full Text] [Related]
17. Pemphigus foliaceus in 91 dogs.
Mueller RS; Krebs I; Power HT; Fieseler KV
J Am Anim Hosp Assoc; 2006; 42(3):189-96. PubMed ID: 16611930
[TBL] [Abstract][Full Text] [Related]
18. Short-term outcomes of induction therapy with tacrolimus versus cyclophosphamide for active lupus nephritis: A multicenter randomized clinical trial.
Chen W; Tang X; Liu Q; Chen W; Fu P; Liu F; Liao Y; Yang Z; Zhang J; Chen J; Lou T; Fu J; Kong Y; Liu Z; Fan A; Rao S; Li Z; Yu X
Am J Kidney Dis; 2011 Feb; 57(2):235-44. PubMed ID: 21177013
[TBL] [Abstract][Full Text] [Related]
19. Oral pemphigus: long term behaviour and clinical response to treatment with deflazacort in sixteen cases.
Mignogna MD; Lo Muzio L; Mignogna RE; Carbone R; Ruoppo E; Bucci E
J Oral Pathol Med; 2000 Apr; 29(4):145-52. PubMed ID: 10766391
[TBL] [Abstract][Full Text] [Related]
20. Successful treatment of refractory mucosal lesions of pemphigus vulgaris using intravenous gammaglobulin as adjuvant therapy.
Wever S; Zillikens D; Bröcker EB
Br J Dermatol; 1996 Nov; 135(5):862-3. PubMed ID: 8977702
[No Abstract] [Full Text] [Related]
[Next] [New Search]
